Our Blog – What moves us

DOES REMDESIVIR KNOCK OUT CORONA?

DOES REMDESIVIR KNOCK OUT CORONA?

Currently, there are intensive reports on the active Remdesivir from the US pharmaceutical giant Gilead. Chemically, the substance is a 1′-cyano 4-aza-7,9-didesazaadenosine C analogue of adenosine: It is a monophosphoramidate prodrug that is converted by metabolism...

mehr lesen
GERMAN UTILITY MODELS – SMART IP WEAPONS

GERMAN UTILITY MODELS – SMART IP WEAPONS

Enforceable intellectual property rights in Europe are of great strategic and economic importance. Many companies, especially from the Far East, are therefore interested in getting their international applications granted quickly in at least one European heartland....

mehr lesen
Halloumi cheese

Halloumi cheese

Halloumi is a cheese made from sheep’s and goat’s milk, traditionally produced in the Eastern Mediterranean. It is particularly typical for the Cypriot cuisine. It is also very popular in Germany, especially among BBQ lovers, because it keeps its shape during grilling...

mehr lesen
THE IMPACT OF BREXIT ON UNION TRADEMARKS

THE IMPACT OF BREXIT ON UNION TRADEMARKS

On 1 February 2020, the United Kingdom left the European Union. BREXIT will also change the IP landscape in Europe. While the field of patents will hardly be affected, as membership in the EPC is not linked to membership in the EU (and the time lag to the European...

mehr lesen
FRIDAYS FOR … TRADEMARKS

FRIDAYS FOR … TRADEMARKS

On the day before Christmas last year, an application was filed for the Union trade mark 018171380 for classes 35, 36, 41 and 42. The services covered range from marketing and sales promotion, financial and cultural activities to the provision of scientific...

mehr lesen

Our Authors

Bernd Fabry is founder and CEO of IP2. He is a qualified German and European Patent and Trademark Attorney. He has more than 25 years company experience as Head of IP departments. 

Dr. Bernd Fabry - CEO

We are pleased that our Scientific Adviser, Dr. Martin Fabry from the University of Cambridge, will now report regularly on new developments in this exciting field.

Dr. Martin Fabry - Scientific Advisor

Subscribe to our newsletter!

Never miss the newest blog post or important information about patents and laws